UDIV-B:CA:TSX-Manulife Smart U.S. Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 14.64

Change

-0.26 (-1.74)%

Market Cap

CAD 0.10B

Volume

500.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

+0.04 (+0.12%)

CAD 5.85B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.03 (-0.06%)

CAD 5.48B
PHYS-U:CA Sprott Physical Gold Trust

+0.44 (+2.20%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.14 (-0.38%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.16 (+0.36%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.15 (+1.55%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.03 (-0.06%)

CAD 2.98B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.09 (+0.40%)

CAD 2.78B

ETFs Containing UDIV-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.03% 64% D 63% D
Dividend Return 2.09% 39% F 27% F
Total Return 19.11% 63% D 61% D-
Trailing 12 Months  
Capital Gain 17.03% 64% D 63% D
Dividend Return 2.09% 39% F 27% F
Total Return 19.11% 63% D 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.36% 58% F 49% F
Dividend Return 4.55% 57% F 44% F
Total Return 0.19% 47% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 7.82% 63% D 81% B-
Risk Adjusted Return 58.15% 75% C 70% C-
Market Capitalization 0.10B 62% D 34% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.